INJECTION SITE PHLEBITIS

This adverse event was reported 234 times

INJECTION SITE PHLEBITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HEMIN 2 0.0034
1 ETOMIDATE INJECTION 5 0.0023
2 ETOMIDATE 5 0.0022
3 FOSAPREPITANT DIMEGLUMINE 26 0.0019
4 EPIRUBICIN HYDROCHLORIDE 12 0.0018
5 SOYBEAN OIL 1 0.0015
6 TEDIZOLID PHOSPHATE 1 0.0012
7 IRON SUCROSE 9 0.0009
8 RILONACEPT 1 0.0009
9 MEPROBAMATE 1 0.0008
See all drugs enriched for association with INJECTION SITE PHLEBITIS

INJECTION SITE PHLEBITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Parenteral Iron Replacement [EPC] 10 0.0007
1 Interferon gamma [EPC] 1 0.0007
2 Lipid Emulsion [EPC] 1 0.0004
3 alpha-1 Adrenergic Agonist [EPC] 1 0.0002
4 CD52-directed Cytolytic Antibody [EPC] 4 0.0002
5 Gadolinium-based Contrast Agent [EPC] 1 0.0002
6 Osmotic Diuretic [EPC] 1 0.0002
7 Radiographic Contrast Agent [EPC] 4 0.0002
8 Phenothiazine [EPC] 4 0.0001
9 General Anesthetic [EPC] 5 0.0001
See all drug classes enriched for association with INJECTION SITE PHLEBITIS